cpc Europa GmbH
Medical Technology · Konstanz
cpc Europa GmbH is a medical technology company based in Konstanz, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
cpc Europa GmbH Address & Contact
cpc Europa GmbH Overview
cpc Europa GmbH is the European subsidiary of CPC (Colder Products Company), a world-leading manufacturer of quick couplings and fluid connection solutions based in Konstanz, Baden-Württemberg. The company develops and produces medical quick couplings for dialysis, infusion therapy, and medical device fluidics. The focus on innovative solutions and high-quality products sets cpc Europa GmbH apart from competitors and strengthens its position in the European market.
Services and Products
CPC produces disposable couplings, reusable couplings, and valves for fluid transfer in medical products and laboratory systems. The biocompatible products are used in hemodialysis machines, infusion systems, leukapheresis systems, and medical laboratory devices, complying with ISO 10993 and MDR requirements. Particularly noteworthy is the company's ability to develop customized solutions that meet the specific requirements of medical applications.
- Disposable couplings: These products are designed for single use to ensure hygiene standards in medical technology. They are used in various areas, including infusion therapy and dialysis.
- Reusable couplings: These are made from high-quality materials and are ideal for use in reusable systems due to their durability.
- Valves: CPC offers a variety of valve types that are used for both fluid transfers and flow control in medical devices.
The company continuously invests in research and development to meet the ever-changing demands of the healthcare market. Through close cooperation with its customers and additional feedback, products can be continuously optimized and improved.
Regulatory Classification and Quality Assurance
CPC Europa GmbH is committed to ensuring the highest standards in quality and safety. The company adheres not only to ISO standards but is also certified according to the requirements of the Medical Device Regulation (MDR). These regulatory frameworks are crucial for the development and marketing of medical products in Europe. Adherence to these standards builds trust among partners and end-users and is a key factor for competitiveness.
Location Konstanz / Baden-Württemberg
Konstanz on Lake Constance is located at the tri-border area of Germany, Austria, and Switzerland and is part of the economically strong Lake Constance economic region. The proximity to the Swiss medtech industry in the Basel region and good transport connections make Konstanz an attractive European headquarters for CPC. The city is not only a center for innovation and technology but also benefits from a high quality of life, which attracts and retains talent.
Additionally, the region is known for its highly developed infrastructure and the close networking of companies and research institutions. This enables cpc Europa GmbH to respond quickly to market changes and launch innovative products promptly. The location plays a decisive role in strengthening the company's position in the European medical technology industry.
Special Features and Future Perspectives
cpc Europa GmbH sees itself as a pioneer in the development of connection solutions for medical technology. The continuous investment in new technologies, such as the development of smart couplings that integrate digital sensors, demonstrates the company's innovative strength. Future perspectives include not only the expansion of the product portfolio but also the exploration of new markets in Europe and worldwide.
In an industry characterized by rapid technological advancement and intense regulation, cpc Europa GmbH remains flexible and adaptable. The clear strategy and commitment to quality will enable the company to continue playing a significant role in medical technology in the future.
Other medical technology companies: Medical Technology Overview | Medical Technology Baden-Württemberg | Contract Manufacturers
Frequently asked questions about cpc Europa GmbH
What does cpc Europa GmbH do?
cpc Europa GmbH is a company in the medical technology sector based in Konstanz. The company develops, manufactures or distributes medical devices, instruments or systems for use in healthcare facilities.
Where is cpc Europa GmbH based?
cpc Europa GmbH is based in Konstanz. Detailed information can be found on the company website.
In which area of medical technology does cpc Europa GmbH operate?
cpc Europa GmbH operates in the medical technology sector and offers solutions for healthcare facilities, hospitals and practices. The exact areas of activity can be found on the company website.
More Medical Technology in Konstanz
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.